Cargando…

Clinical practice guidelines for multigene assays in patients with early-stage breast cancer: Chinese Society of Breast Surgery (CSBrS) practice guidelines 2021

Detalles Bibliográficos
Autores principales: Zhu, Jiu-Jun, Jiao, De-Chuang, Yan, Min, Guo, Xu-Hui, Zhao, Ya-Jie, Chen, Xiu-Chun, Wang, Cheng-Zheng, Lu, Zhen-Duo, Li, Lian-Fang, Cui, Shu-De, Liu, Zhen-Zhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509935/
https://www.ncbi.nlm.nih.gov/pubmed/34561332
http://dx.doi.org/10.1097/CM9.0000000000001409
_version_ 1784582461090430976
author Zhu, Jiu-Jun
Jiao, De-Chuang
Yan, Min
Guo, Xu-Hui
Zhao, Ya-Jie
Chen, Xiu-Chun
Wang, Cheng-Zheng
Lu, Zhen-Duo
Li, Lian-Fang
Cui, Shu-De
Liu, Zhen-Zhen
author_facet Zhu, Jiu-Jun
Jiao, De-Chuang
Yan, Min
Guo, Xu-Hui
Zhao, Ya-Jie
Chen, Xiu-Chun
Wang, Cheng-Zheng
Lu, Zhen-Duo
Li, Lian-Fang
Cui, Shu-De
Liu, Zhen-Zhen
author_sort Zhu, Jiu-Jun
collection PubMed
description
format Online
Article
Text
id pubmed-8509935
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-85099352021-10-13 Clinical practice guidelines for multigene assays in patients with early-stage breast cancer: Chinese Society of Breast Surgery (CSBrS) practice guidelines 2021 Zhu, Jiu-Jun Jiao, De-Chuang Yan, Min Guo, Xu-Hui Zhao, Ya-Jie Chen, Xiu-Chun Wang, Cheng-Zheng Lu, Zhen-Duo Li, Lian-Fang Cui, Shu-De Liu, Zhen-Zhen Chin Med J (Engl) Consensus Statement Lippincott Williams & Wilkins 2021-10-05 2021-09-21 /pmc/articles/PMC8509935/ /pubmed/34561332 http://dx.doi.org/10.1097/CM9.0000000000001409 Text en Copyright © 2021 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/)
spellingShingle Consensus Statement
Zhu, Jiu-Jun
Jiao, De-Chuang
Yan, Min
Guo, Xu-Hui
Zhao, Ya-Jie
Chen, Xiu-Chun
Wang, Cheng-Zheng
Lu, Zhen-Duo
Li, Lian-Fang
Cui, Shu-De
Liu, Zhen-Zhen
Clinical practice guidelines for multigene assays in patients with early-stage breast cancer: Chinese Society of Breast Surgery (CSBrS) practice guidelines 2021
title Clinical practice guidelines for multigene assays in patients with early-stage breast cancer: Chinese Society of Breast Surgery (CSBrS) practice guidelines 2021
title_full Clinical practice guidelines for multigene assays in patients with early-stage breast cancer: Chinese Society of Breast Surgery (CSBrS) practice guidelines 2021
title_fullStr Clinical practice guidelines for multigene assays in patients with early-stage breast cancer: Chinese Society of Breast Surgery (CSBrS) practice guidelines 2021
title_full_unstemmed Clinical practice guidelines for multigene assays in patients with early-stage breast cancer: Chinese Society of Breast Surgery (CSBrS) practice guidelines 2021
title_short Clinical practice guidelines for multigene assays in patients with early-stage breast cancer: Chinese Society of Breast Surgery (CSBrS) practice guidelines 2021
title_sort clinical practice guidelines for multigene assays in patients with early-stage breast cancer: chinese society of breast surgery (csbrs) practice guidelines 2021
topic Consensus Statement
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509935/
https://www.ncbi.nlm.nih.gov/pubmed/34561332
http://dx.doi.org/10.1097/CM9.0000000000001409
work_keys_str_mv AT zhujiujun clinicalpracticeguidelinesformultigeneassaysinpatientswithearlystagebreastcancerchinesesocietyofbreastsurgerycsbrspracticeguidelines2021
AT jiaodechuang clinicalpracticeguidelinesformultigeneassaysinpatientswithearlystagebreastcancerchinesesocietyofbreastsurgerycsbrspracticeguidelines2021
AT yanmin clinicalpracticeguidelinesformultigeneassaysinpatientswithearlystagebreastcancerchinesesocietyofbreastsurgerycsbrspracticeguidelines2021
AT guoxuhui clinicalpracticeguidelinesformultigeneassaysinpatientswithearlystagebreastcancerchinesesocietyofbreastsurgerycsbrspracticeguidelines2021
AT zhaoyajie clinicalpracticeguidelinesformultigeneassaysinpatientswithearlystagebreastcancerchinesesocietyofbreastsurgerycsbrspracticeguidelines2021
AT chenxiuchun clinicalpracticeguidelinesformultigeneassaysinpatientswithearlystagebreastcancerchinesesocietyofbreastsurgerycsbrspracticeguidelines2021
AT wangchengzheng clinicalpracticeguidelinesformultigeneassaysinpatientswithearlystagebreastcancerchinesesocietyofbreastsurgerycsbrspracticeguidelines2021
AT luzhenduo clinicalpracticeguidelinesformultigeneassaysinpatientswithearlystagebreastcancerchinesesocietyofbreastsurgerycsbrspracticeguidelines2021
AT lilianfang clinicalpracticeguidelinesformultigeneassaysinpatientswithearlystagebreastcancerchinesesocietyofbreastsurgerycsbrspracticeguidelines2021
AT cuishude clinicalpracticeguidelinesformultigeneassaysinpatientswithearlystagebreastcancerchinesesocietyofbreastsurgerycsbrspracticeguidelines2021
AT liuzhenzhen clinicalpracticeguidelinesformultigeneassaysinpatientswithearlystagebreastcancerchinesesocietyofbreastsurgerycsbrspracticeguidelines2021